Epidemiology and risk factors of recurrent pelvic organ prolapse
M.R. ORAZOV1, V.E. RADZINSKIY1, F.F. MINNULLINA2
1Peoples’ Friendship University of Russia, Moscow
2KazanFederalUniversity, Kazan
Contact details:
OrazovM.R.—MD, ProfessoroftheDepartmentofObstetricsandGynecologywithacoursein perinatology
Address: 6 Miklukho-Maklaya St., Moscow,Russian Federation, 117198,tel.: +7-915-237-52-92, е-mail:omekan@mail.ru
Pelvic organ prolapse (POP) is an extremely common condition in the female population, which has a negative impact on the quality of life of patients. Pelvic floor muscle dysfunction can be detected by special examination in 50% of women, but no more than 3% of patients complain, due to the asymptomatic course in some situations and the reluctance of patients to discuss unpleasant symptoms with a doctor.
The only effective way to treat POP is surgical intervention, but this method is associated with a number of risks (intra- and postoperative) and a high risk of recurrence (up to 58%). In case of POP symptoms recurrence after a seemingly effective treatment, reoperation is required (about 30% of patients treated before).
There is evidence that the studied risk factors for POP are common to primary pelvic floor dysfunction and to recurrence after surgical treatment. However, it is difficult to assess their isolated contribution to POP recurrence.
The purposeis to analyze and summarize the currently available evidence on the POP frequency of recurrence and risk factors.
Scientific publications of 2014–2024 in PubMed, ELibrary, CochraneLibrary, Science Direct databases were analyzed using the keywords: pelvic organ prolapse, risk factors, pathogenesis, recurrence.
Based on the literature analysis, it is concluded that to date there is no complete understanding of the risk factors for POP recurrence after reconstructive surgery, the data obtained are not standardized and are often contradictory. More precise determination of POP risk factors will help clinicians to choose the surgical methods most acceptable in a particular clinical situation and to optimize pre- and postoperative treatment.
Key words: pelvic organ prolapse, recurrence, risk factors, surgical treatment.
REFERENCES
- Vypadenie zhenskikh polovykh organov: klinicheskie rekomendatsii [Prolapse of female genital organs: clinical recommendations]. Moscow, 2021. P. 47.
- Wu J.M., Hundley A.F., Fulton R.G., Myers E.R. Forecasting the prevalence of pelvic floordisorders in U.S. Women: 2010 to 2050. Obstet Gynecol, 2009, vol. 114(6), pp. 1278–1283.
- Vergeldt T.F., Weemhoff M., IntHout J., Kluivers K.B. Risk factors for pelvic organprolapse and its recurrence: a systematic review. Urogynecol. J, 2015, vol. 26(11), pp. 1559–1573.
- Bola R., Guo M., Karimuddin A. et al. An examination of rectal prolapse surgerypatients’ quality of life and symptoms using patient-reported outcome instruments: A prospective cohort study. J. Surg, 2024, vol. 231, pp. 113–119.
- Weintraub A.Y., Glinter H., Marcus-Braun N. Narrative review of the epidemiology,diagnosis and pathophysiology of pelvic organ prolapse. Braz. J. Urol, 2020, vol. 46(1), p. 514.
- Peinado-MolinaR.A., Hernández-MartínezA., Martínez-VázquezS.etal. Pelvic floordysfunction: prevalence and associated factors. BMC Public Health, 2023, vol. 23(1), p. 2005.
- Hong M.K., Ding D.C. Current treatments for female pelvic floor dysfunctions. Minim. Invasive Ther, 2019, vol. 8(4), p. 143.
- BentiTerefe A., Gemeda Gudeta T., Teferi Mengistu G., Abebe S.S. Determinants of pelvic floor disorders among women visiting the gynecology outpatient department in wolkite university specialized center, wolkite. Ethiopia Obstet. Gynecol. Int, 2022, vol. 13(2022), pp. 1–10.
- Dheresa M., Worku A., Oljira L. et al. One in five women suffer from pelvic floor disorders in Kersa district Eastern Ethiopia: a community-based study. BMC Womens Health, 2018, vol. 18(1), p. 95.
- Wu J.M., Vaughan C.P., Goode P.S. et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Gynecol, 2014, vol. 123(1), pp. 141–148.
- Sawai M., Yuno C., Shogenji M. et al. Prevalence of symptoms of pelvic floor dysfunction and related factors among Japanese female healthcare workers. LUTS, 2022, vol. 14(5), pp. 380–386.
- Malaekah H., al Medbel H.S., al Mowallad S. et al. Prevalence of pelvic floor dysfunction in women in Riyadh, Kingdom of Saudi Arabia: a cross-sectional study. Women’s Health, 2022, vol. 18, 174550652110722.
- Cheung R.Y.K., Chan S.S.C., Shek K.L. et al. Pelvic organ prolapse in Caucasian andEast Asian women: a comparative study. Ultrasound Obstet. Gynecol, 2019, vol. 53(4), pp. 541–
- Glazener C.M., Breeman S., Elders A. et al. PROSPECT study group. Mesh, graft, orstandard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT). Lancet, 2017, vol. 389(10067), pp. 381–392.
- Bohlin K.S., Ankardal M., Nüssler E. et al. Factors influencing the outcome of surgeryfor pelvic organ prolapse. Urogynecol. J, 2018, vol. 29(1), pp. 81–89.
- Shi W., Guo L. Risk factors for the recurrence of pelvic organ prolapse: a metaanalysis. Obstet.Gynaecol, 2023, vol. 43(1), p. 2160929.
- Friedman T., Eslick G.D., Dietz H.P. Risk factors for prolapse recurrence: systematicreview and meta-analysis. Urogynecol. J, 2018, vol. 29(1), pp. 13–21.
- Toozs-Hobson P., Freeman R., Barber M. et al. An International UrogynecologicalAssociation (IUGA)/International Continence Society (ICS) joint report on the terminology for reporting outcomes of surgical procedures for pelvic organ prolapse. Urogynecol. J, 2012, vol. 23(5), pp. 527–535.
- Hallock J.L., Handa V.L. The Epidemiology of pelvic floor disorders and childbirth: an update. Gynecol. Clin. North Am, 2016, vol. 43(1), pp. 1–13.
- de Sam Lazaro S., Nardos R., Caughey A.B. Obesity and pelvic floor dysfunction: battling the bulge. Gynecol. Surv, 2016, vol. 71(2), pp. 114–125.
- Alcalay M., Stav K., Eisenberg V.H. Family history associated with pelvic organprolapse in young women. Urogynecol. J, 2015, vol. 26(12), pp. 1773–1776.
- Vetuschi A., Pompili S., Gallone A. et al. Immunolocalization of advanced glycationend products, mitogen activated protein kinases, and transforming growth factor-β/smads in pelvic organ prolapse. Histochem. Cytochem, 2018, vol. 66(9), pp. 673–686.
- Freitas-Rodríguez S., Folgueras A.R., López-Otín C. The role of matrixmetalloproteinases in aging: Tissue remodeling and beyond. Biophys. Acta Mol. Cell Res, 2017, vol. 1864(11 Pt A), pp. 2015–2025.
- Veit-Rubin N., Cartwright R., Singh A.U. et al. Association between jointhypermobility and pelvic organ prolapse in women: a systematic review and meta-analysis. Urogynecol. J, 2016, vol. 27(10), pp. 1469–1478.
- Falah-Hassani K., Reeves J., Shiri R. et al. The pathophysiology of stress urinaryincontinence: a systematic review and meta-analysis. Urogynecol. J, 2021, vol. 32(3), pp. 501–552.
- Madueke-Laveaux O.S., Elsharoud A., Al-Hendy A. What we know about the long-term risks of hysterectomy for benign indication-a systematic review. Clin. Med, 2021, vol. 10(22), p. 5335.
- Chen V., Shackelford L., Spain M. Pelvic floor dysfunction after hysterectomy: moving the investigation forward. Cureus, 2021, vol. 13(6), p. e15661.
- Cartwright R., Kirby A.C., Tikkinen K.A. et al. Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women. J. Obstet Gynecol, 2015, vol. 212(2), pp. 199.e1–24.
- Diez-Itza I., Avila M., Uranga S. et al. Factors involved in prolapse recurrence oneyear after anterior vaginal repair. Urogynecol. J, 2020, vol. 31(10), pp. 2027–2034.
- Yeung E., Malacova E., Maher C. Is levator ani avulsion a risk factor for prolapserecurrence? A systematic review and meta-analysis. Urogynecol. J, 2022, vol. 33(7), pp. 1813–1826.
- Kayondo M., Geissbüehler V., Migisha R. et al. Risk factors for recurrence of pelvicorgan prolapse after vaginal surgery among Ugandan women: a prospective cohort study. Urogynecol. J, 2022, vol. 33(7), pp. 1933–1939.
- Schulten S.F., Detollenaere R.J., IntHout J. et al. Risk factors for pelvic organ prolapserecurrence after sacrospinous hysteropexy or vaginal hysterectomy with uterosacral ligament suspension. J. Obstet. Gynecol, 2022, vol. 227(2), pp. 252.e1–252.e9.
- Nahshon C., Karmakar D., Abramov Y. et al. Risk factors for pelvic organ prolapserecurrence following colpocleisis: A meta-analysis. J. Gynaecol. Obstet, 2024, vol. 164(3), pp. 848–856.